🧬Anthropic Acquires Computational-Biology Startup Coefficient Bio for $400M
Anthropic Acquires Computational-Biology Startup Coefficien…
TL;DR
Anthropic acquired Coefficient Bio, an eight-month-old computational biology startup built by former Evozyne, Genentech, and Prescient Design researchers, for …
Anthropic acquired Coefficient Bio, an eight-month-old computational biology startup built by former Evozyne, Genentech, and Prescient Design researchers, for $400 million in stock. The deal marks Anthropic's first direct bet on AI-native drug discovery.
Key Points
$400M all-stock acquisition of Coefficient Bio
Team came from Evozyne, Genentech, and Prescient Design
Startup was just eight months old at time of deal
Anthropic's first dedicated biology / drug-discovery acquisition
Why It Matters
Frontier AI labs are now buying biology teams outright, signaling that drug discovery is a strategic front in the AGI race, not a side bet.
Frequently Asked Questions
Why does this matter?
Frontier AI labs are now buying biology teams outright, signaling that drug discovery is a strategic front in the AGI race, not a side bet.
What happened?
Anthropic acquired Coefficient Bio, an eight-month-old computational biology startup built by former Evozyne, Genentech, and Prescient Design researchers, for …
Comments
Be the first to comment
Enjoyed this article?
Get it daily. 7am. Free. Reads in 5 minutes.
Join 3,313 builders reading daily.